We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:ALNY
logo

Alnylam Pharmaceuticals (ALNY)

Nasdaq • ALNY • US02043Q1076

147.82Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 4, 2026, ORTEX estimated 4.8% of free float sold short, 2.5 days to cover, cost to borrow 0.33%. Sign up for live short interest data.

Market Cap

21b USD | # 945 in US

Volume

2.08m shares | 455.68m USD

Shares Outstanding

133.94m

Free Float Shares

99.77% | 133.63m

DB:DUL|
XTRA:DUL|
LSE:0HD2|
BOVESPA:A1LN34|
BIT:1ALNY|
WBAG:ALNY

News

ALNY key data

Alnylam Pharmaceuticals (Nasdaq: ALNY) has a market capitalization of $20.96B. Last close $147.82 (as of 2026-11-20); 52-week range $146.51 to $479.79. ORTEX data as of 2026-11-04: short interest was 4.75% of free float, 2.5 days to cover and the average cost to borrow was 0.33%. Sign up for live short interest data.

Latest on ALNY

  • Jul 31, 2026ALNY Craters 28% on Earnings — Street Slashes Targets but Holds Ratings
  • May 20, 2026ALNY Bulls Grab the Wheel Into Q1 Print
All ALNY news on ORTEX News
  • ALNY news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.